C-reactive protein and IL-6: New marker proteins for the diagnosis of CJD in plasma?

Transfusion

Volumn 41, Issue 12, 2001, Pages 1509-1514

  Völkel, Dirk ^a   Zimmermann, Klaus ^a   Zerr, Inga ^a   Lindner, Thomas ^a   Bodemer, Monica ^a   Poser, Sigrid ^a   Schwarz, Hans Peter ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; NEURON SPECIFIC ENOLASE; PRION PROTEIN; PROTEIN S 100;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; NERVE CELL LESION; PROTEIN ANALYSIS;

BIOLOGICAL MARKERS; BIOPSY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; HUMANS; INFLAMMATION; INTERLEUKIN-6; PHOSPHOPYRUVATE HYDRATASE; PRIONS; S100 PROTEINS;

EID: 0035689506     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41121509.x     Document Type: Article

References (46)

1. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995
2. Novel proteinaceous infectious particles cause scrapie
3. Molecular biology of prion diseases
4. Scrapie prions aggregate to form amyloid-like birefringent rods
5. A cellular gene encodes scrapie PrP 27-30 protein
6. Conversion of alphahelices into beta-sheets features in the formation of the scrapie prion proteins
7. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders
8. The 14-3-3 brain protein cerebrospinal fluid as a marker for transmissible spongiform encephalopathies
9. Isoform pattern of 143-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
10. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease
11. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease
12. 14-3-3 Testing in diagnosing Creutzfeldt-Jakob disease: A prospective study in 112 patients
13. Reduced phosphorylation of mitogen-activated protein kinase in response to insulin in cells with truncated C-terminal domain of insulin receptor
14. Elevated levels of tauprotein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
15. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease
16. 14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
17. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
18. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control study
19. Serum markers of brain damage and outcome prediction in patients after severe head injury
20. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases
21. Increased serum concentrations of protein S-100 after minor head injury: A biochemical serum marker with prognostic value?
22. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography
23. Brain enolases as specific markers of neuronal and glial cells
24. Neuronal, non-neuronal and hybrid forms of enolases in brain: Structural, immunological and functional comparisons
25. S100a0 (alpha alpha) protein is present in neurons of the central and peripheral nervous system
26. Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction
27. Acute phase proteins in the monitoring of inflammatory disorders
28. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines
29. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
30. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice
31. Pathology of Creutzfeldt-Jakob disease associated with pituitaryderived human growth hormone administration
32. Neuronal apoptosis in fatal familial insomnia
33. Neuronal apoptosis in Creutzfeldt-Jakob disease
34. Heightened intrathecal release of proinflammatory cytokines in CreutzfeldtJakob disease
35. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies
36. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens
37. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes
38. Regulation of complement activation by C-reactive protein
39. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease
40. Temporary depletion of complement component C3 or genetic deficiency of Clq significantly delays onset of scrapie
41. Complement facilitates early prion pathogenesis
42. Radioimmunoassay development for human neuron-specific enolase: With some clinical results in lung cancers and neuroblastoma
43. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder
44. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid
45. Plasma S-100b protein concentration in healthy adults is ageand sex-independent